Patents Assigned to SPHINGOTEC THERAPEUTICS GMBH
  • Publication number: 20190145981
    Abstract: The present invention is directed to methods for determining active DPP3 in a bodily fluid sample, an assay or kit for determining active DPP3 in a bodily fluid sample, a method for diagnosing a disease or condition in a subject accompanied by or related to necrotic processes and methods of treating or preventing said disease.
    Type: Application
    Filed: April 20, 2017
    Publication date: May 16, 2019
    Applicant: SPHINGOTEC THERAPEUTICS GMBH
    Inventor: Andreas BERGMANN